SARS-CoV-2 seroprevalence and clinical features of COVID-19 in a German liver transplant recipient cohort: a prospective serosurvey study

In liver transplant (LT) recipients with severe coronavirus disease 2019 (COVID-19), fatal outcome has been reported in a substantial subset of patients. Whether LT recipients are at increased risk for severe COVID-19 compared with the general population is controversial. Here we report the results...

Full description

Saved in:
Bibliographic Details
Main Authors: Rauber, Conrad (Author) , Tiwari-Heckler, Shilpa (Author) , Pfeiffenberger, Jan (Author) , Mehrabi, Arianeb (Author) , Lund, Frederike (Author) , Gath, Philip (Author) , Mieth, Markus (Author) , Merle, Uta (Author) , Rupp, Christian (Author)
Format: Article (Journal)
Language:English
Published: 28 May 2021
In: Transplantation proceedings
Year: 2021, Volume: 53, Issue: 4, Pages: 1112-1117
ISSN:1873-2623
DOI:10.1016/j.transproceed.2020.11.009
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.transproceed.2020.11.009
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0041134520329043
Get full text
Author Notes:Conrad Rauber, Shilpa Tiwari-Heckler, Jan Pfeiffenberger, Arianeb Mehrabi, Frederike Lund, Philip Gath, Markus Mieth, Uta Merle, and Christian Rupp
Description
Summary:In liver transplant (LT) recipients with severe coronavirus disease 2019 (COVID-19), fatal outcome has been reported in a substantial subset of patients. Whether LT recipients are at increased risk for severe COVID-19 compared with the general population is controversial. Here we report the results of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurvey in a large LT recipient cohort.
Item Description:Available online 16 December 2020
Gesehen am 22.09.2022
Physical Description:Online Resource
ISSN:1873-2623
DOI:10.1016/j.transproceed.2020.11.009